GHUCCTS

News

Share This
  • Oct 22, 2020

TIN convalescent plasma study by former GHUCCTS KL2 scholar Dr. Seble Kassaye featured on NBC4

Dr. Seble Kassaye, infectious disease expert at Georgetown University Medical Center and former GHUCCTS KL2 scholar, is the principal investigator for a local convalescent plasma COVID-19 clinical trial. Dr. Kassaye recently appeared on NBC4 Washington to discuss the trial.

This trial is led by Johns Hopkins University. MedStar Georgetown University HospitalMedStar Washington Hospital Center, and Georgetown University Medical Center are serving as subsites for the trial, with support from GHUCCTS and the Trial Innovation Network (TIN). This study is for people at high risk of exposure to COVID-19, such as hospital personnel (clinical staff, environmental services, dining services, etc) or anyone who is caring for someone with COVID-19. This study will test whether an infusion of plasma containing antibodies from persons who have recovered from COVID-19 can prevent others from getting it.

Please visit www.covidplasmatrial.org/ or call 888-506-1199 for more information. 

Promotional flyer for Dr. Kassaye's COVID-19 plasma trial. Visit covidplasmatrial.org for more details.

Related News

Request for Applications: 2021-2022 TL1 Translational Biomedical Science Program

Feb 19, 2021

The GHUCCTS TL1 Translational Biomedical Science (TBS) Program is now accepting applications for our 2021-2022 funding cycle. Applicants should be predoctoral students who have completed their qualifying exams in PhD programs at Howard or Georgetown Universities or Postdoctoral fellows who have a primary appointment at Georgetown or Howard Universities, a MedStar Institution, or the Washington DC VAMC.

International Science of Team Science Conference Call for Abstracts

Feb 12, 2021

The International Science of Team Science Conference is now accepting abstract proposals for its 12th annual conference June 7-11, 2021. This year's conference theme is "Science of Team Science and the Human Condition". The deadline to submit abstracts is February 28, 2021.

MedStar Health's COVID-19 Community Research Partnership

Feb 12, 2021

Join MedStar Health in learning more about COVID-19 in our Community. MedStar Health is conducting a real-time COVID-19 surveillance study to better understand COVID-19 spread and vaccine adoption within our community. If you are age 18 or older, we need YOU to help us improve COVID-19 prevention strategies that will benefit you, your family members, and the larger community. Go to MedStarHealth.org/JoinTheFight and click the button to sign up for the study. You only need to be over 18 years old and have an email address to be part of the study.

Close